National Networks for Radiotherapy Dosimetry Audits / IAEA, issuing body.

Format:

Book

Contributor:

International Atomic Energy Agency, issuing body.

Series:

IAEA human health reports ; Volume 18.

IAEA Human Health Reports ; Volume 18

Language:

English

Subjects (All):

Cancer--Treatment.

Cancer.

Neoplasms radiotherapy.

Radiation dosimetry.

Radiation--Measurement.

Radiation.

Radiotherapy--Quality control.

Radiotherapy.

Radiotherapy--Safety measures.

Radiotherapy standards.

Physical Description:

1 online resource (117 pages)

Edition:

First edition.

Place of Publication:

Vienna, Austria : International Atomic Energy Agency, [2023]

Summary:

This publication, produced by the International Atomic Energy Agency (IAEA), addresses the critical aspect of quality assurance in radiotherapy dosimetry audits. It focuses on the structure, methodology, and scientific procedures necessary for conducting effective dosimetry audits at national levels. The book provides a comprehensive framework for establishing national dosimetry audit networks, highlighting the importance of precise radiation dosing in cancer treatment. It discusses the development and implementation of audit methodologies through coordinated research projects, offering guidance for organizations aiming to enhance dosimetry accuracy in radiotherapy centers. The publication serves as a reference for implementing independent quality audits, enhancing the safe and effective delivery of radiation therapy to cancer patients. Generated by AI.

Contents:

Intro

1. Introduction

1.1. Radiotherapy provision for cancer treatment

1.2. Accuracy required in radiotherapy

1.3. Qa in radiotherapy

1.4. Discrepancies in radiation treatment

1.5. The need for independent quality audit in radiotherapy generally and in radiotherapy dosimetry

1.6. Iaea and other approaches to independent quality audit of radiotherapy dosimetry

1.7. Extension of the scope of radiotherapy dosimetry audit within the iaea framework

1.8. Scope of the publication

2. Overview of Coordinated Research proJects on dosimetry audit in radiotherapy

2.1. Overview of the framework of the development of the audits

2.2. Overview of the process for the development of audits

2.2.1. Background

2.2.2. Process for audit development

3. Guidelines for establishing A national Dosimetry audit network for radiotherapy

3.1. Introduction

3.2. Aim of the dan

3.3. National radiotherapy infrastructure database

3.4. Structure of the dan

3.5. Dac development and operations

3.6. Dac audits and required resources

3.7. Summary

4. Audit steps - methodology and testing

4.1. Step 1: tld audits for photon beams in reference conditions

4.1.1. Introduction to the step 1 audit

4.1.2. Methodology of the step 1 audit

4.1.3. Development and testing of the step 1 audit methodology

4.1.4. Results of the national runs for the step 1 audit

4.1.5. Summary and conclusions for the step 1 audit

4.2. Step 2a: tld audits for photon beams in non‑reference conditions

4.2.1. Introduction to the step 2a audit

4.2.2. Methodology of the step 2a audit

4.2.3. Development and testing of the step 2a audit methodology

4.2.4. Results of the national runs for the step 2a audit

4.2.5. Summary and conclusions for the step 2a audit.

4.3. Step 2b: tld audits for electron beams in reference and non‑reference conditions on the beam axis

4.3.1. Introduction to the step 2b audit

4.3.2. Methodology of the step 2b audit

4.3.3. Development and testing of the step 2b audit methodology

4.3.4. Results of the national runs for the step 2b audit

4.3.5. Summary and conclusions for the step 2b audit

4.4. Step 3: Audits for photon beams in reference conditions and non‑reference conditions off‑axis

4.4.1. Introduction to the step 3 audit

4.4.2. Methodology of the step 3 audit

4.4.3. Development and testing of the step 3 audit methodology

4.4.4. Results of the national runs for the step 3 audit

4.4.5. Summary and conclusions for step 3 audit

4.5. Step 4: dose audits of complex treatment technique parameters: irregular photon beams shaped with an mlc

4.5.1. Introduction to the step 4 audit

4.5.2. Methodology of the step 4 audit

4.5.3. Development and testing of the step 4 audit methodology

4.5.4. Results of the national runs for the step 4 audit

4.5.5. Summary and conclusions for the step 4 audit

4.6. Step 5: audits of complex treatment parameters for photon beams

situations involving heterogeneities

4.6.1. Introduction to the step 5 audit

4.6.2. Methodology of the step 5 audit

4.6.3. Development and testing of the step 5 audit methodology

4.6.4. Results of the national runs for the step 5 audit

4.6.5. Summary and conclusions for the step 5 audit

4.7. Step 6: audits of complex treatment parameters: small photon fields shaped by an mlc

4.7.1. Introduction to the step 6 audit

4.7.2. Methodology of the step 6 audit

4.7.3. Development and testing of the step 6 audit methodology

4.7.4. Results of the national runs for the step 6 audit

4.7.5. Summary and conclusions for the step 6 audit.

4.8. Step 7a: quality audits of output factors of small fields shaped with mlc

4.8.1. Introduction to the step 7a audit

4.8.2. Methodology of the step 7a audit

4.8.3. Development and testing of the step 7a audit methodology

4.8.4. Results of the national runs for the step 7a audit

4.8.5. Summary and conclusions for the step 7a audit

4.9. Step 7b: film quality audit of mlc performance for imrt dose delivery

4.9.1. Introduction to the step 7b audit

4.9.2. Methodology of the step 7b audit

4.9.3. Testing of the step 7b audit methodology

4.9.4. Results of the national runs for the step 7b audit

4.9.5. Summary and conclusions for the step 7b audit

4.10. Step 8: film quality audit for relative dosimetry of a photon beam single imrt field

4.10.1. Introduction to the step 8 audit

4.10.2. Methodology of the step 8 audit

4.10.3. Development and testing of the step 8 audit methodology

4.10.4. Results of the national runs for the step 8 audit

4.10.5. Summary and conclusions for the step 8 audit

4.11. Step 9: 'end‑to‑end' dosimetric quality audit for imrt, including imaging, treatment planning and delivery

4.11.1. Introduction to the step 9 audit

4.11.2. Methodology of the step 9 audit

4.11.3. Development and testing of the step 9 audit methodology

4.11.4. Results of the national runs for the step 9 audit

4.11.5. Summary and conclusions for the step 9 audit

5. CONCLUSION

Appendix I CHARACTERISTICS OF TLD SYSTEMS OF DOSIMETRY AUDIT CENTRES

Appendix II CHARACTERISTICS OF THE FILM DOSIMETRY SYSTEM

REFERENCES

LIST OF ABBREVIATIONS

ANNEX: SUPPLEMENTARY FILES

CONTRIBUTORS TO DRAFTING AND REVIEW.

Notes:

Description based on publisher supplied metadata and other sources.

Part of the metadata in this record was created by AI, based on the text of the resource.

Description based on print version record.

Includes bibliographical references.

Other Format:

Print version: National Networks for Radiotherapy Dosimetry Audits

ISBN:

9789201311214

9201311214

OCLC:

1409030801